Dr. Eric Floyd serves as the Principal and CEO at Floyd Regulatory Strategic Consulting. In this role, he works to successfully propel operational growth (P&L) and drug development for pharmaceutical companies. Prior to his current role, Dr. Floyd  previously served as the Chief Regulatory Officer at Neurogene, the Senior Vice President of Global Regulatory Affairs at Axovant Sciences, the President of  Compliance Services and the Chief Scientific Officer at Dohmen Life Science  Services, and as the Vice President of Regulatory Affairs and Quality Assurance at  Lundbeck. Dr. Floyd received his B.S. from University of Illinois Urbana-Champaign, his M.Sc. in Neuroscience from Tennessee State University, his Ph.D. in Neurophysiology from Meharry Medical College, his Executive M.B.A. from Saint  Joseph’s University, and an International M.B.A. from INSEAD.